European Healthtech startup funding raised during Q4 2015.
In Q4 2015, 76 European Healthtech companies raised a combined €571M across 77 funding rounds, up 59.4% versus Q4 2014. UK led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
3 exits · €196M disclosed.
| €32M |
| PREP Biopharm | Series A | Oct 2015 | €29M |
| NovImmune | Series D+ | Dec 2015 | €27M |
| Kesios Therapeutics | Series A | Nov 2015 | €27M |
| EIMindA | Series C | Oct 2015 | €25M |
| ElMindA | Series C | Oct 2015 | €25M |
| Babylon Health | Growth/Late | Dec 2015 | €23M |
| GamaMabs Pharma | Series B | Nov 2015 | €15M |
| Sophia Genetics | Series C | Nov 2015 | €14M |
| Equipe Zorgbedrijven | Growth/Late | Oct 2015 | €13M |
| KAHR Medical | Growth/Late | Nov 2015 | €11M |
| ConceptoMed | Growth/Late | Dec 2015 | €11M |
